Sabiad
Develops a monoclonal antibody for visualization of Staphylococcus aureus-associated infections related to orthopedic implants.
Launch date
Employees
Heerenveen Friesland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Spinout | |
* | N/A | - | |
| Total Funding | - | ||